What's New on the FDA Drugs Site
August 8, 2012
- Drugs@FDA Download File (updated)
- Guidance for Industry: Guidance Agenda - New & Revised Draft Guidances CDER is Planning to Publish During Calendar Year 2012
New and Generic Drug Approvals
August 7, 2012
| Drug Name | Active Ingredient | Dosage Form/Route | Sponsor | Submission Type |
|---|---|---|---|---|
| Oxaliplatin | oxaliplatin | Injectable; Iv (Infusion) | Onco Therapies Ltd | Approval |
| Viread | tenofovir disoproxil fumarate | Tablet; Oral | Gilead Sciences Inc | Efficacy Supplement with Clinical Data to Support |
| Viread | tenofovir disoproxil fumarate | Powder; Oral | Gilead Sciences Inc | Efficacy Supplement with Clinical Data to Support |
| This email was sent to kostikblog@ukr.net using GovDelivery, on behalf of: U.S. Food & Drug Administration (FDA) · 10903 New Hampshire Ave · Silver Spring, MD 20993 · 800-439-1420 |  |
